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ABSTRACT 
Dehydroabietic acid (DHA, 1), a natural occurring diterpene resin acid, is an abundant resin acid in conifers, representing a natural wood protectant. 
The aim of this study was to use microbial cell cultures as tools for modification of 1 in order to obtain value-added functional derivatives. A scaled-
up biotransformation of 1 by filamentous fungus Cunninghamella elegans, Rhizopus stolonifer, Gibberella fujikuroi, and Cephalosporium aphidicola 
were conducted for the first time. Three hydroxylated metabolites; 1β-hydroxydehydroabietic acid (2); 15-hydroxy dehydroabietic acid (3); and 16-
hydroxy dehydroabietic acid (4). The structure of the hydroxylated metabolites were elucidated by 1-D (1H, 13C) and 2-D NMR (COSY, HMBC, HMQC, 
NOESY) techniques and MS analyses. Dehydroabietic acid (1) and their transformed products 2-4 exhibited a promising α-Glucosidase inhibitory 
activity. Compound 1 showed 38 times more active than the standard α-Glucosidase inhibitor
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Dehydroabietic acid (Abieta-8,11,13-trien-18-oic acid, 1
Microbial transformation has been useful tool for in vitro drug 
metabolism studies [7-8]. The advantages of using microorganisms 
such as bacteria and fungi for the production of metabolites are that 
the cultures are relatively easy to maintain and grow, and that scale-
up to produce milligram or gram amounts is readily accomplished. 
In addition, a variety of metabolites could be obtained by microbial 
transformations, from which more active metabolites might be 
found. In recent years, many research works frequently reported to 
modify the structures of natural products for finding some novel 
biotransformed reactions, or some new chemical entities with the 
proper drugability [8-33]. Moreover, microorganisms such as fungi 
and bacteria can provide better yields of the metabolites when 
compared with in vivo metabolism studies, producing enough 
material for toxicological and biological assays. Fungi of the genus 
Cunninghamella stand out amongst other genera because can 
catalyze reactions mimicking the mammalian metabolism. 
Cunninghamella species are capable of metabolizing a wide variety 
of xenobiotics using both phase I and phase II reactions, oftentimes 
giving rise to new compounds [8-23]. The microbial-oriented 
oxidation of terpene under mild conditions appears as an attractive 
alternative as compared to the traditional chemical methods, have 
an elevated regio- and enantioselectivity, and do not generate toxic 
waste products, and the products obtained can be labeled as 
“natural”source [24-33].  
), a natural 
occurring diterpenic resin acid, is an abundant resin acid in conifers, 
representing a natural wood protectant. It is also one of the 
constituents found in byproducts of the kraft chem. pulping 
industry. Dehydroabietic acid (DHA, 1) and its derivatives has been 
found to have properties of enhancing the inhibition activity of 
anticancer drug in various cells, such as hepatocellular carcinoma 
cells, cervical carcinoma cells, and breast cancer cells. It has been 
shown that DHA treatment decreases plasma glucose and insulin 
levels with plasma triglyceride (TG) and hepatic TG levels. DHA is 
also a useful food-derived compound for treating obesity-related 
diseases [1-6].  
In present work, biotransformation of Dehydroabietic acid (1) by 
filamentous fungus Cunninghamella elegans TSY 0865, Rhizopus 
stolonifer ATCC-10404, Gibberella fujikuroi ATCC-10704 and 
Cephalosporium aphidicola IMI-68689 were carried out for the first 
time (Scheme 1). Three hydroxylated transformed products were 
isolated and identified in the biotransformation process of 1. In 
addition, the 
MATERIALS AND METHODS 
α-glucosidase inhibitory activity and antibacterial 
activities of metabolites 2-4 were evaluated (Table 1 and 2).  
General  
Dehydroabietic acid (1) was purchased from sigma-aldrich (USA). 
Melting points were determined on a Yanaco MP-S3 apparatus. UV 
spectra were measured on a Shimadzu UV 240 spectrophotometer. 
JASCO DIP–360 Digital polarimeter was used to measure the optical 
rotations in chloroform by using 10 cm cell tube. FTIR-8900 
Spectrophotometer was used to record IR spectra in CHCl3. The 1H-
NMR and 2D NMR spectra were recorded on a Bruker Avance III 500 
spectrometer, while 13C-NMR spectra were recorded on Bruker 
Avance III 500 spectrometer operating at 125 MHz using CDCl3 as 
solvent. chemical shifts were reported in δ (ppm), relative to SiMe4 
as internal standard, and coupling constants (J) were measured in 
Hz. The HREI MS were measured on Jeol HX 110 mass spectrometer. 
TLC was performed on Si gel precoated plates (PF254 , 20 × 20, 0.25 
mm, Merck, Germany). Ceric sulphate in 10% H2SO4 
Fungi and culture conditions 
spraying 
reagent was used for the staining of compounds on TLC. All reagents 
used were of analytical grades. 
Microbial cultures of the Cunninghamella elegans TSY 0865 was 
grown on Potato dextrose agar (PDA) at 25 C and stored at 4 C. 
Cunninghamella elegans TSY 0865 medium was prepared by adding 
Glucose (10.0 g), peptone (5.0 g), KH2PO4
Microbial cultures of the Rhizopus stolonifer ATCC-10404 was grown 
on Potato dextrose agar (PDA) at 25 C and stored at 4 C. Medium 
 (5.0 g), yeast extract (5.0 
g), NaCl (5.0 g) and glycerol (10 mL) into distilled water (1 L) and 
maintained pH at 5.6.  
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for Rhizopus stolonifer was prepared by mixing Glucose (20.0 g), 
Peptone (5.0 g), Yeast extract (3.0 g) and KH2PO4
Microbial cultures of the Gibberella fujikuroi ATCC-10704 was grown 
on Potato dextrose agar (PDA) at 25 C and stored at 4 C. Medium 
for Gibberella fujikuroi was prepared by mixing Glucose (80.0 g), 
NH
 (5.0 g) into 
distilled water (1 L) and maintained pH at 5.6. 
4NO3 (1.0 g), KH2PO4 (5.0 g), MgSO4.7H2
Microbial cultures of the Cephalosporium aphidicola IMI-68689 was 
grown on Potato dextrose agar (PDA) at 25 C and stored at 4 C. 
Medium for Cephalosporium aphidicola was prepared by mixing 
Glucose (50.0 g), KH
O (1.0 g) and Gibberella 
trace element solution (2.0 mL) into distilled water (1 L) and 
maintained pH at 5.6. 
2PO4 (1.0 g), MgSO4.7H2
general stage ii fermentation and extraction procedure 
O (2.0 g), Glycin (2.0 g), 
KCl (1.0 g) and Gibberella trace element solution (2.0 mL) into 
distilled water (1 L) and maintained pH at 5.6.  
The fungal media were transferred into 250 mL conical flasks (100 
mL each) and autoclaved at 120 C. Seed flasks were prepared from 
three-day old slant and fermentation was allowed for two days on a 
shaker at 25 C. The remaining flasks were inoculated from seed 
flasks. After one days, Dehydroabietic acid (1) (1 g) was dissolved in 
20 mL of acetone and transferred in each flask and the clear solution 
was evenly distributed among the 40 flasks, containing 24-h-old 
stage-II cultures. Fermentation was carried out for 12 days on a 
rotatory shaker (200 rpm) at 25° C. For TLC analysis, the content of 
one flask each was harvested every second day. The culture media 
and mycelium were separated by filtration. The mycelium was 
washed with CH2Cl2 (1.5 L), and the filtrate was extracted with 
CH2Cl2
1β-hydroxy dehydroabietic acid (2):  
 (12 L). The resulting brown gummy extracts (1.48, 1.62, 
1.49, and 1.51 g for R. stolonifer, C. elegans, G. fujikuroi and 
C.aphidicola, respectively) were purified by repeated column 
chromatography (petroleum ether/EtOAc gradients). From these 
extracts, following compounds were isolated: 2 (8.1 mg); PE/ EtOAc 
(81:19), 3 (11.3 mg); PE/ EtOAc (82:18), and 4 (13.8 mg); PE/ EtOAc 
(85:15). 
amorphous material (8.1 mg); [α]25 D:  +14° (c = 0.24, CHCl3); Rf: 0.5 
(Pet. Ether/EtOAc 82:18); EI-MS m/z (rel. int., %): m/z 316 [M+] 
(24), 302 (59), 218 (21), 170 (14), 154 (67), 86 (32), 70 (61), 43 
(100); HREI-MS (mol. formula, calcd value): m/z 316.1528 
(C20H28O3, 316.1536); 1H-NMR (CDCl3, 500 MHz) δ: See [24]; 13C-
NMR (CDCl3
15-hydroxydehydroabietic acid (3):  
, 125 MHz) δ: See [25]. 
white solid (11.3 mg); [α]25 D:  +31° (c = 0.24, CHCl3); Rf: 0.5 (Pet. 
Ether/EtOAc 82:18); EI-MS m/z (rel. int., %): m/z 316 [M+] (62), 302 
(12), 218 (61), 170 (38), 154 (52), 86 (62), 70 (48), 43 (100); HREI-
MS (mol. formula, calcd value): m/z 316.1479 (C20H28O3, 316.1492); 
1H-NMR (CDCl3, 500 MHz) δ: See [25], 13C-NMR (CDCl3
16-hydroxydehydroabietic acid (4):  
, 125 MHz) δ: 
See [26]. 
amorphous material (13.8 mg); [α]25 D:  +68° (c = 0.24, MeOH); Rf: 0.5 
(Pet. Ether/EtOAc 82:18); EI-MS m/z (rel. int., %): m/z 316 [M+] 
(62), 302 (19), 218 (51), 170 (19), 154 (37), 86 (52), 70 (100); 
HREI-MS (mol. formula, calcd value): m/z 316.1528 (C20H28O3, 
316.1536); 1H-NMR (CDCl3, 500 MHz) δ: See [26]; 13C-NMR (CDCl3
α-Glucosidase enzyme inhibition assay 
, 
125 MHz) δ: See [27]. 
α-Glucosidase (E.C.3.2.1.20) enzyme inhibition assay has been 
performed according to the slightly modified method of Matsui et al. 
α-Glucosidase (E.C.3.2.1.20) from Saccharomyces sp. Was purchased 
from Wako Pure Chemical Industries Ltd. (Wako 076-02841). The 
inhibition was measured spectrophotometrically at pH 6.9 and at 
37° C using 0.7mM p-nitrophenyl α-D glucopyranoside (PNP-G) as a 
substrate and 250 m units/mL enzyme in 50mM sodium phosphate 
buffer containing 100mM NaCl. 1- Deoxynojirimycin (0.425mM) and 
acarbose (0.78mM) were used as positive controls. The increment in 
absorption at 400nm due to the hydrolysis of PNP-G by α-
glucosidase was monitored continuously with the 
spectrophotometer (Molecular Devices, CA, USA) [15].  
Estimation of IC50
The concentrations of the test compounds, which inhibited the 
hydrolysis of PNP-G by α-glucosidase by 50% (IC
 values 
50), were 
determined by monitoring the effect of increasing the concentration 
of these compounds on the inhibition values. The IC50
Zone of inhibition assay 
 values were 
then calculated by using EZ-Fit enzyme kinetics program (Perrella 
Scientific Inc., Amherst, MA, USA) [15]. 
Test sample (3 mg) was taken and dissolved in 3 mL of DMSO (1 
mg/mL). Molten nutrient agar (45 mL) was poured on the sterile 
petri plates and was allowed to solidify. Bacterial lawn was made on 
these nutrient agar plates by dispensing 7 mL sterile soft agar 
containing 100 mL of cultures of the test organisms. Wells were 
dugged with the help of 6 mm sterile metallic borer at appropriate 
distances, then 100 µL of sample was poured into each well and the 
plates were incubated at 37º C for 24 hours. The results in terms of 
zones of inhibition were recorded. Imiperium was used as a positive 
control, while DMSO was used as a negative control. All the 
chemicals used were of analytical grades (Sigma, USA) [20].  
RESULTS AND DISCUSSION 
Fermentation of dehydroabietic acid (1) for 12 days with 
Cunninghamella elegans TSY 0865, Rhizopus stolonifer ATCC-10404, 
Gibberella fujikuroi ATCC-10704 and Cephalosporium aphidicola IMI-
68689 resulted three regio- and stereoselective hyroxyl products, 2-
4 (Scheme 1). The HREI MS of metabolite 2 exhibited the molecular 
ion (M+) at m/z 316.1536, corresponding to the formula C20H28O3, 
which indicated that a new oxygen functionality was introduced 
during fermentation period. Metabolite 2 was found to be 1β-
hydroxy derivative of 1, based on 1H and 13C NMR signals at δH 
3.92/δC
Metabolite 3 was obtained as a white powder (Scheme 1). Its 
molecular formula was determined as C
 76.8. Hydroxylation at C-1 position was further supported 
by COSY and HMBC interactions. The β-orientation of C-1 OH group 
was deduced on the basis of NOESY correlations between H-1 (δ 
3.92) and H-5 (δ 2.20). The structure of known metabolite 2 (1β-
hydroxydehydroabietic acid) was further deduced by comparison 
with the reported data (Gouiric et al., 2004). Metabolite 2 was 
previously obtained by the fermentation of 1 with Fusarium 
oxysporum, F. moniliforme and Aspergillus niger [25]. 
20H28O3 according to the 
HREI MS data (m/z 316.1479: calcd for C20H28O3, 316.1492), 
indicated that one oxygen had been incorporated into the molecule, 
as compared to 1. Metabolite 3 was found to be 15-hydroxy 
derivative of 1, based on 13
Metabolite 4 was obtained as an amorphous material (Scheme 1). 
The HREI MS of metabolite 3 exhibited the molecular ion (M
C NMR signals at δ 72.3. The position of 
the newly introduced hydroxyl at C-15 position was inferred from 
the HMBC coupling of C-16 and C-17 methyl protons with C-15 (δ 
72.3). The structure of known metabolite 3 (15-
hydroxydehydroabietic acid) was further deduced by comparison 
with the reported data [26]. 
+) at m/z 
316.1528, corresponding to the formula C20H28O3, indicating an 
introduction of a new oxygen in the molecule, probably as OH during 
fermentation period. Compound 4 was found to be C-16 hydroxy 
derivative of 1, based on NMR signals at δH 3.64/δC
Dehydroabietic acid (1) and its transformed products 2-4 were 
subjected to 
 68.7 and further 
confirm by comparison with the reported data [27]. The position of 
the newly introduced hydroxyl at C-16 position was inferred from 
the HMBC coupling of H-15 and C-17 methyl protons with C-16 (δ 
68.7).  
α-glucosidase Inhibitory Activity. According to the 
results, the dehydroabietic acid (1) showed a promising inhibitory 
effect, which is 38 times more than the standard deoxynojirimycin. 
The activity of 2 was also found to be much better than the 
transformed products 2-4 (Table 1). This may be due to binding of 
substrate 2 with the enzyme binding site through hydrophobic 
Atif et al. 
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interactions. Introduction of hydroxyl groups through 
transformation such as in metabolites 2-4, increase the 
hydrophilicity, which may cause formation of the hydrogen bonding 
with surrounding buffer system, thus the hydrophobic interactions 
with the binding site is distorted, thus a decrease in the overall α-
glucosidase inhibitory activities was observed. Among the 
transformed products, compound 4 showing more inhibitory 
activity than the compound 2 probably due to hydroxylation at 
isopropyl side chain causing less steric hindrance, which help in the 
binding with the enzyme.  
 
Table 1: α-Glucosidase Inhibitory Activity of Compounds 1-4 








Dehydroabietic acid (1) and its transformed products 2-4 were 
tested for their antibacterial activity against two Gram-positive 
bacteria including Bacillus subtilis and Staphylococcus aureus, in 
addition to four Gram-negative bacteria (Escherichia coli, Shigella 
flexneri, Pseudomonas aeruginosa and Salmonella typhi) using 
previously reported zone of inhibition test method [19]. All 































demonstrated significant antibacterial activities against various 
strains maybe due to the presence of OH group at C-16 position 
(Table 2). 
 
Scheme 1: Fermentation of dehydroabietic acid (1) by 
Cunninghamella elegans, Rhizopus stolonifer, Gibberella 
fujikuroi, and Cephalosporium aphidicola. 
 











1 15 17 15 15 17 Inactive 
2 11 Inactive 11 14 Inactive 
3 
Inactive 
10 Inactive 10 12 Inactive 
4 
Inactive 
19 20 12 16 Inactive 20 
Imipenem  30 33 27 33 24 25 
 
CONCLUSIONS 
In summary, the present research on the biotransformation of 
dehydroabietic acid (1) by Cunninghamella elegans, Rhizopus 
stolonifer, Gibberella fujikuroi, and Cephalosporium aphidicola have 
been conducted for the first time. Fermenation of 1 for 12 days with 
fungal strains yielded three hydroxylated transformed products 2-4. 
Structures of all new metabolites were elucidated by using 
spectroscopic techniques. All compounds 1-4 were then subjected to 
α-glucosidase Inhibitory Activity and antibacterial activities. 
Compound 1 showed promising inhibitory effect against α-
glucosidase, which is 38 times more than the standard 
deoxynojirimycin. All metabolites 2-4 exhibited antibacterial activity but 
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